Kerry Flom - Concepedia

Author

Kerry Flom

University of Southern California

Also Known As

K J Flom, K. J. Flom, KERRY FLOM, Kerry Flom, Kerry J Flom, Kerry J. Flom

Publications

Citations

H-Index

Concepts

All Affiliations

University of Southern California

About

Kerry Flom is an author at University of Southern California specializing in medicine, pathology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	268
2	Pathology	2	2	268
3	Cell Biology	1	1	10
4	Immunology	1	1	10
5	Cancer Therapeutics	1	1	10

Kerry Flom

Publications

Citations

H-Index

Page 1

	Year	Citations
HER-2/neu gene amplification characterized by fluorescence in situ hybridization: poor prognosis in node-negative breast carcinomas. Michael F. Press, Leslie Bernstein, P. Thomas, Journal of Clinical Oncology	1997	810
Evaluation of HER-2/<i>neu</i> Gene Amplification and Overexpression: Comparison of Frequently Used Assay Methods in a Molecularly Characterized Cohort of Breast Cancer Specimens Michael F. Press, Dennis J. Slamon, Kerry Flom, Journal of Clinical Oncology	2002	388
Clinical evaluation of a multi-target fluorescent in situ hybridization assay for detection of bladder cancer. Michael F. Sarosdy, Paul F. Schellhammer, Gary Bokinsky, PubMed	2002	273
Clinical Evaluation of a Multi-target Fluorescent in Situ Hybridization Assay for Detection of Bladder Cancer Michael F. Sarosdy, Paul F. Schellhammer, Gary Bokinsky, The Journal of Urology Tumor BiologyUrological ResearchUrologyOncologyTransitional Cell Carcinoma	2002	258
Alteration of Topoisomerase II–Alpha Gene in Human Breast Cancer: Association With Responsiveness to Anthracycline-Based Chemotherapy Michael F. Press, Guido Sauter, Marc Buyse, Journal of Clinical Oncology	2010	220
Evaluation of school children at high risk for fragile X syndrome utilizing buccal cell FMR‐1 testing Randi J. Hagerman, Philip Wilson, Louise W. Staley, American Journal of Medical Genetics	1994	49
Association of topoisomerase II-alpha (TOP2A) gene amplification with responsiveness to anthracycline-containing chemotherapy among women with metastatic breast cancer entered in the Herceptin H0648g pivotal clinical trial MF Press, R. Mass, Jiaxi Zhou, Journal of Clinical Oncology Gene AmplificationTop2a Gene AmplificationBreast OncologyImmunologyPathology	2005	10

Page 1